English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Jamie Barrand | Dec 15, 2015

Ninlaro approved by FDA as multiple myeloma treatment

Jamie Barrand | Dec 15, 2015

Celiac disease at center of Takeda, Cour research partnership

Jamie Barrand | Dec 15, 2015

Eliquis shown to be effective treatment for deep vein thrombosis, pulmonary embolism

Jamie Barrand | Dec 15, 2015

Biogen's ALS therapy research shows promise

Kim Sunderland | Dec 14, 2015

Criticism mounts as Maine's Obamacare-funded co-op ceases individual enrollment

Kerry Goff | Dec 14, 2015

Obamacare expense drives closure of popular Nashville restaurant

Kerry Goff | Dec 14, 2015

U.S. Justice Department expert discusses how insurance mergers could hurt consumer premiums

Jamie Barrand | Dec 12, 2015

Ibrance may be effective for post-menopausal breast cancer patients

Trending

+ Pharmaceuticals
Patient Daily | Sep 23, 2025

Wall Street Journal editorial board alleges hospitals misuse 340B program

+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program

+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Staff Attorney of Legal Aid Society on 340B: 'Hospitals are exploiting the 340B program'

+ Marketing
Patient Daily | Sep 17, 2025

Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'

  • « First
  • «
  • …
  • 253
  • 254
  • 255
  • 256
  • 257
  • 258
  • 259
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily